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A key question in pandemic influenza is the relative roles of innate immunity and target cell depletion in
limiting primary infection and modulating pathology. Here, we model these interactions using detailed data
from equine influenza virus infection, combining viral and immune (type I interferon) kinetics with estimates
of cell depletion. The resulting dynamics indicate a powerful role for innate immunity in controlling the rapid
peak in virus shedding. As a corollary, cells are much less depleted than suggested by a model of human
influenza based only on virus-shedding data. We then explore how differences in the influence of viral proteins
on interferon kinetics can account for the observed spectrum of virus shedding, immune response, and
influenza pathology. In particular, induction of high levels of interferon (“cytokine storms”), coupled with
evasion of its effects, could lead to severe pathology, as hypothesized for some fatal cases of influenza.
Influenza A virus causes an acute respiratory disease in
humans and other mammals; in humans, it is particularly im-
portant because of the rapidity with which epidemics develop,
its widespread morbidity, and the seriousness of complications.
Every year, an estimated 500,000 deaths worldwide, primarily
of young children and the elderly, are attributed to seasonal
influenza virus infections (49). Influenza pandemics may occur
when an influenza virus with new surface proteins emerges,
against which the majority of the population has no preexisting
immunity. Both the emergence of H5N1 virus (34) and the
current H1N1 virus pandemic (43) underline the importance of
understanding the dynamics of infection and disease. A key
question is, what regulates virus abundance in an individual
host, causing the characteristic rapid decline in virus shedding
following its initial peak? The main contenders in primary
influenza virus infection are depletion of susceptible target
cells and the impact of the host’s innate immune response
(2, 20).
On infection, the influenza virus elicits an immune response,
including a rapid innate response that is correlated with the
observed decline in the virus load after the first 2 days of
infection (1). The slower adaptive response, including both
humoral and cell-mediated components, takes several days to
consolidate but is important for complete virus clearance and
establishment of protective immunity. During infection of an
immunologically naïve host, the innate immune response is
particularly important as the first line of defense against infec-
tion. The innate immune response is regulated by chemokines
and cytokines, chemical messengers produced by virus-infected
epithelial cells and leukocytes (23), and natural interferon-
producing cells, such as plasmacytoid dendritic cells (13).
Among the key cytokines induced by epithelial cells infected
with influenza A virus are type I interferons (IFNs) (IFN-/)
(23), which directly contribute to the antiviral effect on in-
fected and neighboring cells (38).
Like other viruses, influenza A viruses have evolved strate-
gies to limit the induction of innate immune responses (38).
The NS1 protein plays a dominant role, and without it, the
virus is unable to grow well or to cause pathology in an immu-
nocompetent host (14). NS1 is multifunctional and counteracts
both the induction of IFN expression and the function of
IFN-activated antiviral effectors via multiple mechanisms (12,
17). Individual strains of influenza A virus possess these activ-
ities to various degrees (15, 21, 22, 26), and accordingly, NS1
has been implicated as a virulence factor (3, 17). A striking
effect of the failure to control the innate response to virus
infection is seen as a “cytokine storm,” which causes severe
pathology (8).
While there is an extensive literature on modeling influenza
virus spread at the population level, the individual-host scale
has received much less attention (2, 4, 5, 18, 19, 20, 27, 28). In
a recent important paper, Baccam et al. modeled the kinetics
of influenza A virus (2). The innate dynamics were included in
the form of an IFN response that delayed and reduced virus
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production but did not prevent it; thus, the infection was re-
solved primarily through near-total depletion of epithelial
cells. Their model was fitted to virus titers from human volun-
teers exposed to H1N1 influenza virus, but no data were avail-
able on the innate immune response or epithelial cell pathol-
ogy. This has been a general difficulty in developing and
validating more refined within-host models; there is a lack of
detailed biological data from natural host systems, in particu-
lar, measures of immune kinetics and patterns of cellular de-
pletion.
The model presented here explicitly includes the ability of
IFN to induce a fully antiviral state in order to explore the
relative regulatory role of innate immunity and target cell
depletion. Data from experimental infections of immunologi-
cally naïve horses with an equine influenza virus (36) allowed
us to calibrate our model, not only to viral kinetics, but also to
IFN dynamics and cell depletion in the context of infection of
a naïve natural mammalian host. With our fitted model, we
then investigate modulation of the immune response.
MATERIALS AND METHODS
Description of data sets. The study used data from experiments that were
previously undertaken for other purposes and that had gone through full insti-
tutional ethical review at the time, and most of the data have been published
(36). Virus shedding data (daily measures of RNA copies per milliliter of nasal
secretion up to 10 days) and cytokine data (IFN fold change daily from days 1 to
5 postinfection) were obtained as part of an experiment to study the effect of
vaccination on proinflammatory cytokine expression in horses after exposure to
influenza virus (36). Data for individual horses from the control group, immu-
nologically naïve horses, are presented here (only grouped data were given in
reference 36).
Archived samples of lung tissues were available from four immunologically
naïve yearling Welsh mountain ponies that were experimentally infected in 1988
by exposure to an aerosol of 106.6 50% egg infectious doses of A/equine/New-
market/79 (H3N8) influenza virus (31) and that were killed at days 2.5, 3.5, 4.5,
and 5.5 after infection. Sections of left cranial lung samples were stained with
FIG. 1. Experimental data. (a to c) The numbers of uninfected (blue) and infected (red) respiratory epithelial cells were determined for each
bronchiole in a left cranial lung sample from archived samples from an experimental infection of three immunologically naïve horses. The
distribution of infection is shown for 2.5 (a), 4.5 (b), and 5.5 (c) days postinfection. The bronchioles were sorted in ascending order with respect
to the number of epithelial cells they contained. (d) Total percentages of infection at 2.5, 4.5, and 5.5 days postinfection were determined to be
1.93%, 4.73%, and 1.87%, respectively (circles). A simple function (solid curve) was interpolated to these data points to estimate the cumulative
percentage of cells infected over the course of infection (27%).
TABLE 1. Parameters of the innate-response model
Parameter Symbol Unit Value Reference
Epithelial cell population T0 Cells 3.5  10
11 46
Initial virus load V0 RNA copies (ml NS)
1 Fitted
Infectivity rate  (RNA copies)1 ml NS day1 Fitted
IFN-reduced infectivity m 1
Virus production p RNA copies (ml NS)1 day1 cell1 Fitted
Free-virus clearance c Rate of virus clearance day1 5.2 2
IFN efficiency  (IFN fold change)1 day1 Fitted
IFN production q IFN fold change day1 cell1 Fitted
IFN-reduced production n 1
IFN clearance d Rate of IFN clearance day1 Fitted
Eclipse phase period 1/ki Days 1/2 23
Infectious period 1/ Days 1/2 23
Prerefractory state 1/a Days 1/4 11
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horseradish peroxidase-linked polyclonal antibody to influenza A virus nucleo-
protein (as described previously [9]), and the number of infected cells was
determined. The numbers of uninfected and infected epithelial cells per bron-
chiole in the sample from the left cranial lung were then scored visually. The
cumulative percentage of infected cells over time was estimated by interpolation
(of a cubic spline) to the total percentage of infected cells at each time point. The
area under the curve was calculated (by numerical integration) and normalized
by the life span of an infected cell. This gave an estimated total cell death, as it
was assumed that all infected cells were killed by infection.
Fitting procedure. A weighted nonlinear least-squares procedure was used to
fit the model. The sum of the squared errors (SSE), given below, between model
values and data points was minimized.
SSE logVi logVˆilogVˆmax 
2
 Fi FˆiFˆmax 
2
 D Dˆ	2
Weights are used to make errors dimensionless. For the virus shedding, the
difference between model, Vi, and observed, Vˆi, shedding is divided by the max-
imum observed shedding of an individual horse, Vˆmax, each of them in the log
scale. An analogous definition is used for the errors corresponding to IFN
secretion between the model, Fi, and the data, Fˆi, with maximum IFN secretion,
ˆFmax. The squared difference between predicted, D, and estimated, Dˆ, propor-
tions of total cell death is also added to the SSE. Minimum detection levels for
virus shedding are included in the fitting procedure to take into account negative
experimental results. These detection levels are implemented by assuming a zero
difference between the model and the data whenever both quantities are below
these levels. Similarly, if the model is above the minimum detection level but the
data are not, then only the difference between the model and the minimum
detection level is considered. The numerical procedure was implemented using
the function fminsearch in Matlab R2008b (The Mathworks).
RESULTS
Estimates of lung pathology in influenza virus-infected po-
nies. To examine the levels of cell depletion during an influ-
enza virus infection, we estimated the numbers of viral-anti-
gen-positive cells in the lungs of ponies at days 2.5, 4.5, and 5.5
after challenge with influenza A/eq/Newmarket/79 (H3N8) vi-
rus (Fig. 1a to c). Immunohistochemistry indicated only a low
percentage of infected cells, corresponding to an estimated
total cell death of about 27% by the end of the infection (Fig.
1d). This estimate was dependent on the estimated life span of
an infected cell (Table 1). However, the majority of bronchi-
oles with infected cells were not seriously disrupted, indicating
that most cells were not destroyed. This is consistent with
observations in other hosts, where only limited foci of infection
are seen, even in fatal cases (16, 47). These levels of infection
suggest a mechanism for infection control other than substan-
tial cell depletion (2), prompting us to develop a model for
infection that included a strong innate immune response of the
host to infection.
Mathematical model of influenza virus infection dynamics.
In this model formulation, epithelial cells of the respiratory
tract (the target cells of the virus) are classified according to
their infection state. Uninfected epithelial cells (T) are in-
fected at a rate proportional to the virus load (V), with the
constant of proportionality  (to directly link the model to the
data, we defined the virus load, V, as the number of RNA
copies per milliliter of nasal secretion). These newly infected
cells spend an average time of 1/k1 days in an eclipse phase
(E1) before they start releasing progeny virus particles. The
infectious cells (I) release viruses at a rate p per day and have
an average life span of 1/ days. As an influenza virus infection
is likely to be cleared in about 7 days (32) and it takes around
5 days for the epithelium to start to regenerate (47), epithelial
cell regeneration is not considered in the model. Indeed, even
if logistic growth of epithelial cells is added to the model, there
is no effect on the disease dynamics: infection rates predomi-
nate over cell regeneration rates (data not shown). Thus far,
the model constructed in this way is the same as the target
cell-limited model with delayed virus production of Baccam et
al. (2). With this model, and in agreement with the results
of Baccam et al., the infection is controlled by the exhaustion
of epithelial cells, which is inconsistent with the proportion of
dead cells shown in Fig. 1.
The host innate immune response was added to the model to
explore its relative contribution as a mechanism for infection
control, reflecting the crucial and well-described role of IFN in
limiting virus spread (1). We assumed that infectious cells
release IFN (F) during their life span at a rate q per day. IFN
induces an antiviral state (R) at a rate F in susceptible cells
(T). Refractory cells (R) first go through a prerefractory state
(W) for an average time of 1/a, during which they can still be
infected at a rate mV (lower than or equal to that of fully
susceptible cells, 0 
 m  1) (11, 40). If infected, these cells
FIG. 2. Diagram of the infection dynamics. Epithelial cells were
classified into one of the following classes: susceptible (T), eclipse
phase (E1 and E2), infectious (I), prerefractory (W), and refractory (R).
Virus particles (V) are released by infectious cells, while interferon is
secreted by infectious and eclipse phase (I and E2) cells.
TABLE 2. Parameter estimates for the innate-response modela
Pony no. V0  p q  d SSE
1 4.3  101 1.6  104 2.2  106 2.6  1010 3.7  100 1.8  100 0.23
2 1.4  104 3.8  105 2.4  104 1.5  109 7.3  102 2.1  101 0.16
3 1.8  101 4.0  104 3.5  106 4.6  1010 8.8  101 2.7  101 0.46
4 1.9  103 4.2  105 1.3  104 3.5  1010 6.0  102 4.0  100 0.17
5 7.3  102 8.5  104 4.9  106 7.9  1010 1.5  102 8.1  100 0.20
6 1.0  101 1.4  103 1.4  106 1.9  108 1.2  101 1.0  102 0.16
Avgb 3.2  101 1.4  104 1.4  105 5.0  1010 5.6  101 6.8  100 1.8
a Estimated parameters based on experimental data from Quinlivan et al. (36): V0, initial virus load; , virus infectivity; p, virus production per cell; d, IFN clearance
rate; , IFN efficiency; and q, IFN induction per cell. Parameters units are shown in Table 1.
b For the “average horse,” all data were pooled for model fitting.
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move to an eclipse phase (E2) and secrete IFN at a rate nq per
day, because they have been exposed to IFN and primed into
an antiviral state (39). After an average time of 1/k2 days spent
in this eclipse stage, the cells become infectious. It was
assumed that the virus and IFN load decay at rates c and d,
respectively. Parameter definitions and corresponding units
are given in Table 1. The complete dynamics are illustrated
in Fig. 2, and the corresponding equations are given in
system 1.
dT/dt  VT FT
dE1/dt VT k1E1
dW/dt FTmVW aW
dE2/dtmVW k2E2
dR/dt aW
dI/dt k1E1  k2E2 I
dV/dt pI cV
dF/dt nqE2 qI dF
We estimated the parameters for viral kinetics and innate
immune response (p, q, V0, d, , and ) by fitting the model, by
nonlinear least squares, to the virus shedding and IFN profiles
of six immunologically naïve horses (data from reference 36)
and to the estimated proportion of total cell death (parameter
estimates are shown in Table 2; average estimates were ob-
tained by fitting the model to the pooled data). This experi-
mental data set consisted of longitudinal measurements of the
virus load estimated from nasal swabs and of interferon (rela-
tive quantification in blood) in experimentally infected naïve
ponies. The remaining parameters were selected as follows.
Sedmak and Grossberg (40) reported a minimum of about 6 h
to be necessary for the development of maximum resistance to
challenge with influenza virus in primary chicken embryo cell
cultures—this value was therefore taken as the time spent by a
cell in a prerefractory state (i.e., 1/a  1/4 days). The times
FIG. 3. Model dynamics. The innate-response model was fitted to individual virus shedding (RNA copies per milliliter of nasal secretion [NS]) and
IFN (fold change) profiles of six immunologically naïve horses infected with A/equine/Kildare/89 (H3N8) virus (36) and to the estimated total cell death
of 27%. (First and third rows) The virus shedding (red circles), IFN (blue triangles), and model output (solid and dashed curves, respectively) for each
horse are shown. The minimum detection level for the virus load is drawn as a red horizontal line (negative results are plotted as zeros). (Second and
fourth rows) Cell dynamics as predicted by the model (susceptible cells [T], dotted blue lines; infectious cells [I], dashed red lines; total numbers of
epithelial cells, solid black lines). The purple triangles on the top right show the total percentages of cell death estimated in Fig. 1d.
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spent by an infected cell in the incubation and infectious
classes were each taken as 12 h (i.e., ki   2). This gave 24 h
for the life span of an infected cell, which is consistent with
published data (23). The average rate of virus clearance was
chosen as 5.2 per day (i.e., c  5.2), as reported previously (2).
Stone et al. (46) estimated the epithelial cell population size of
the equine respiratory tract (T0) as 3.5  10
11 cells. The value
for the parameters m and n were chosen as 1 as a first approx-
imation (different value choices are discussed in the Appen-
dix). Table 1 contains a summary of all of the parameters in the
model.
Figures 3 and 4 show the fitted model, which captures the
experimental data well. In particular, the correct timings are
identified for both peak virus loads and IFN activity, and the
sharp peak of IFN response is remarkably well described by the
model (Fig. 3, first and third rows). The model predicts that
the majority of epithelial cells become refractory during infec-
tion (Fig. 3, second and fourth rows). This model does not
require total cell death to control infection, consistent with
observed data (Fig. 1a to c). Using the Akaike information
criterion (AIC) (6), the model is very clearly supported for this
data set over the IFN response model of Baccam et al. (for
further details, see the Appendix).
While our model gives clear qualitative results and captures
the data well, some care must be taken when interpreting
individual parameter estimates. Even in this relatively simple
model, there may be some redundancy among the parameters.
In particular, it is hard to disentangle viral production per cell
and the rate of virus transmission (see Fig. A1 and further
discussion in the Appendix). Where possible from the litera-
ture, some of the parameters were preset to fixed values (i.e.,
, k1, k2, a, c, m, and n) (Table 1); the impact of varying these
is discussed in the Appendix. Despite these caveats, a consis-
tent picture emerged of strong innate immunity (and not target
cell depletion) limiting typical primary influenza virus infection
in horses.
Immune evasion and immunopathology. Our calibrated
model of viral and immune dynamics allows exploration of how
variations in IFN induction and IFN efficiency (defined here as
the rate at which IFN induces a refractory state in a susceptible
target cell) can affect the spectrum of virus replication, tissue
damage, and subsequent pathology. Experimental data show
differences between engineered influenza virus mutants (37,
44) and different virus strains (48) in how they interact with the
innate immune system and cause disease; much of this varia-
tion is mediated by viral factors (including different forms of
the NS1 protein [37, 44]), which can affect either the induction
of IFN or its efficiency in limiting virus growth (12, 17).
Varying the rate of IFN induction per cell gives an inverse
relationship (Fig. 5a) between the percentage of cell death and
the total amount of IFN produced (as the rate of IFN induc-
tion per cell is increased, total cell death decreases while total
IFN produced increases). This variation can account for the
findings of Solo´rzano et al. (44) and Quinlivan et al. (37), in
which genetically engineered mutants of swine and equine
influenza viruses, respectively, with truncated NS1 proteins
unable to inhibit IFN induction were attenuated. Moreover,
Solo´rzano et al. (44) reported a correlation between virus titers
and lung lesions and a negative correlation between virus titers
and IFN induction, which are both consistent with our model’s
predictions (Fig. 5a). In contrast, when the IFN efficiency is
varied (Fig. 5b), a large percentage of cell death can occur
despite the presence of increased amounts of IFN, as the virus
evades the antiviral effects of IFN.
The full spectrum of the immune response can be explored
by varying both the IFN induction and IFN efficiency together
(the effects on cell death, total IFN production, and peak virus
load are shown in Fig. 5c to e). With this dynamic range, the
model can describe some observed phenomena. For example,
Wattrang et al. compared virus shedding and IFN levels in two
groups of horses infected with different strains of equine in-
fluenza virus (48). While the titers of virus shed were similar,
the total IFN produced was greater and the clinical signs were
more severe following infection with one strain. This can be
captured in our model by high IFN induction and a low IFN
efficiency against that strain (Fig. 5d to e, lower right of each
plot).
Overall pathology of influenza virus infection. Both cell
death and damage to surviving cells caused by excessive
amounts of IFN must be taken into account when considering
the impact of infection on host pathology. A high level of
cytokines may itself be harmful to the host (7). We defined a
quantitative measure for the overall damage to the host as
follows: damage  death  (1  death)  f(IFN), where death
is the proportion of cell death at the end of infection and
FIG. 4. Model dynamics; pooled data. The innate-response
model was fitted to virus shedding and IFN responses of all six
horses and to the estimated total cell death of 27%. (a) The virus
shedding of each horse is drawn as a cross and the model output as
a solid curve. The minimum detection level for the virus load is
drawn as a horizontal line (negative results are plotted as zeros). (b)
The IFN response (fold change) for each horse is given at each
cross and the model output as a solid curve. (c) Cell dynamics as
predicted by the model. Uninfected cells, T (dotted curve); infected
cells, I (dashed line); and the total number of epithelial cells (solid
curve) are shown. The triangle on the top right shows the total
percentage of cell death estimated in Fig. 1d.
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f(IFN) is an increasing function of the total amount of IFN
(defined as shown in Fig. 6a). This function f is chosen so that
moderate amounts of IFN have little detrimental effect while
the effect of large amounts of IFN on surviving cells is no worse
than cell death.
Similarly, a measure of the benefit to the virus can be de-
fined in terms of the total amount of virus shed and the total
IFN produced. Higher levels of IFN are associated with in-
creased nasal discharge and coughing (19, 42, 48), which could
increase the chances of between-host transmission, which is of
benefit to the virus. This measure is explicitly defined as fol-
lows: benefit  total virus  g(IFN), where g is taken as shown
in Fig. 6b. This particular choice of g assumes that IFN could
increase the transmission probability by up to 50%.
Figures 6c and d show the host damage and the benefit to
the virus against both IFN induction and efficiency. The worst
damage is obtained in the region where IFN efficiency is low
and IFN induction is either very high or low, whereas the
greatest benefit to the virus is seen only where efficiency is low
and induction is high. The exact regions of critical host damage
and benefit to the virus (Fig. 6c and d) depend on specific
choices of the functions f and g, but we expect these results to
hold qualitatively across a range of appropriate f and g func-
tions.
Severe human cases of H5N1 infection have been associated
with hypercytokinemia (7, 10, 35), and recent work suggests
that the 1918 pandemic strain may also have stimulated an
unusually strong innate immune response (24, 25). This is
sometimes described as a cytokine storm (8) and corresponds
in our model to high IFN induction (Fig. 6c and d, right edge).
However, our model output suggests that high IFN induction
alone is not sufficient to produce severe damage; it must be
coupled with poor IFN efficiency (Fig. 6c). Interestingly, there
is some evidence to suggest that the H5N1 influenza virus may
evade the effect of IFN (41).
DISCUSSION
The within-host dynamics of natural virus infection and the
resulting immune responses underlie both the disease signs
seen in infected hosts and virus transmission, thus providing
the foundation for the evolutionary dynamics and public health
impact of the virus on a global scale. Our model, calibrated by
experimental data from an influenza virus infection of a natu-
ral host, successfully captures several aspects of the within-host
dynamics of influenza virus in immunologically naïve individ-
uals and demonstrates the critical role of the innate immune
response in controlling early infection. Resource limitation of
the virus “predator,” in terms of depletion of susceptible cells,
plays an important role as a regulatory mechanism in primary
infection. However, innate immunity seems to be the central
regulatory force, providing a protected state for target cells,
rather than total cell death, as suggested from models in re-
cently published work (2). The relevance of innate immunity
was also highlighted for murine influenza virus, where it was
FIG. 5. Spectrum of the immune response. (a and b) Both the total IFN produced (blue lines) and the peak virus load (red lines) were
normalized to their baseline values and plotted on log base 10; cell death (black lines) is shown as a percentage. These values are all plotted against
the rates of IFN induction per cell, q (a), or IFN efficiency,  (b), both on a log scale normalized by their baseline values (average estimates from
Table 2). (c to e) Contours plotted for various rates of IFN induction per cell, q, and IFN efficiency, , both on a log scale normalized by their
baseline values (X marks the baseline values). Cell death (c) is shown as a percentage, while both total IFN produced (d) and the peak virus load
(e) were normalized by baseline values and plotted on log base 10. The color scale on the right gives the values of this measure in each contour
of the graph.
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required to describe the infection dynamics in a model that
included adaptive immunity (20).
The qualitative results of viral modulation of immunity apply
in a wide range of settings and can be used to explore specific
scenarios. In particular, the model allows a dynamic interpre-
tation of the spectrum of pathology, which is key for under-
standing the impact of an emerging virus. Interestingly, the
relationship between virus shedding and pathology is far from
simple. Virus abundance is predicted to be fairly stable across
a wide spectrum of viral immune escape phenotypes, consistent
with data from natural hosts (48); this arises from the balance
of nonlinear effects on virus growth. These dynamics are even
more complex when infections in primed hosts are considered;
a modification to our model suggests a potentially important
trade-off between innate and adaptive immunity (data not
shown), a key area for future research. Overall, a modeling
approach provides us with a greater understanding of the com-
plex relationship between disease and viral dynamics for an
important pathogen.
Even though this is a simple model, a number of caveats
arise. The model was fitted to observed equine data, but even
this simple model is somewhat overspecified, requiring richer
data sets to produce precise parameter estimates for specific
virus strains and host species. Ideally, parallel viral, innate and
adaptive immune, and pathology data from natural hosts
would be available; indirect (nondestructive) methods for mea-
suring target cell depletion would be particularly useful. An-
other interesting frontier is within-host spatial variation in vi-
rus abundance, pathology, and immunity.
Infectious epithelial cells (and IFN-primed eclipse phase cells)
are assumed to be the only producers of antiviral cytokines in our
model. However, it is recognized that plasmacytoid dendritic cells
are potent producers of IFN in the body (13). In addition, our
model focuses mainly on primary infection, where infection is at
its highest and only the innate immune response may play an
important role (as would be the case in pandemic influenza).
However, to have the complete picture, the explicit dynamics of
the adaptive immune response must be included, as antibodies
and cytotoxic T lymphocytes (CTLs) are recognized as playing
important roles in the clearance of infection (30, 33). While it is
relatively easy to extend compartmental models to include addi-
tional components of the immune system, such as these, model
development must be guided by appropriate data for meaningful
progress to be made.
The current paper provides a template for models based on
data on influenza dynamics within hosts. Extending this ap-
proach to humans, birds, and other host species, as well as to
the impact of interventions, such as drug treatment (29), would
yield a rich harvest in terms of elucidating the cross-scale
dynamics and evolution of this key virus.
APPENDIX
Robustness of the model and fitting algorithm: cross-comparison of
models and data sets. To test the robustness of our model and to
validate our fitting algorithm, we fitted our model of innate immunity
to the data from Baccam et al. (2), and also vice versa (fitting the model
from Baccam et al. to the data set used in our study). Our innate-
immunity model was successfully fitted to the virus-shedding data from
studies of human patients used by Baccam et al. (see Table 1 in
reference 2). Parameter values similar to those reported by Baccam et
al. were obtained, and the sum of squared errors was slightly reduced
(data not shown).
Similarly, the IFN response model from Baccam et al. (2) was fitted
to the equine data used in the present study (36), consisting of both
FIG. 6. Host damage and benefit to the virus. (a) Relative damage of IFN to surviving cells (a logistic function between 0 and 1). (b) Relative
increase in benefit for the virus as a function of IFN (a logistic function between 1 and 1.5). (c and d) Both host damage (c) and benefit to the
virus (d), as defined in the text, are plotted as functions of IFN induction, q, and IFN efficiency, . Both axes are shown on a log scale normalized
by baseline values. The color scales on the right give the values of these measures in each contour of the graphs.
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virus shedding and interferon activity. The SSEs were similar to those
obtained with our model (Table A1), but as previously discussed, the
infection was controlled by the total depletion of target cells. Further-
more, using the AIC (6), our innate-response model had the lowest
score (with a difference of 52.9 in the AIC), which suggests that our
model provides a more parsimonious explanation of the data from the
equine studies (Table A1). Some care needs to be taken in these AIC
computations, due to the large number of parameters (36 or 42) in
comparison with the size of the data set (90). We use a small-sample
bias adjustment suggested by Burnham and Anderson (6), giving the
AIC formula AIC  2K  n log(SSE/n)  [2K(K  1)]/(n  K  1),
where K is the total number of parameters, n is the total number of
data points, and SSE is the cumulative sum of squared errors.
We advise caution when looking at this model comparison, since not
all of the parameters in both models were estimated and then used in
the computation of the AIC values. However, since the numbers of
neglected parameters in each model are similar and the difference in
AIC values is relatively high, we still expect our model to be favored
over the model of Baccam et al.
Difficulties in separating parameters. In our innate-response model,
the rate of change of virus abundance depends directly on the rate of
virus production per cell, p, and the abundance of infectious cells,
which in turn depends on the rate of virus transmission, . As these
parameters interact in their effects, there is a strong linkage between
the fittings for the two parameters. For a given virus abundance, the
greater the virus production per cell, the fewer cells that need to be
infected to obtain a given virus load (Fig. A1a). While the product of
these two parameters (p and ) can be reasonably estimated, it is
currently very hard to give a narrow estimate of either separately. This
can be seen in Fig. A1a, where the peak of best fit is stretched along a
hyperbolic curve in the p-versus- plane. This hyperbolic curve is
defined by   p  min  pmin, where the point (pmin, min) gives the
minimum SSE (all other parameters are fixed to average estimates
from Table 2). The dynamics of the model are obtained at each point
along this hyperbolic curve (Fig. A1b to d). For each value of p, the
contours of the virus load (Fig. A1b), IFN response (Fig. A1c), and
number of refractory cells (Fig. A1d) are shown as a function of time
(according to how the infection develops). As the value of p is varied
but the product is kept constant (so that  is given by min  pmin/p),
the contours in Fig. A1b to d are vertical for a wide range of p. This
means that the dynamics of the virus load, IFN activity, and refractory
cells are not sensitive to the parameters independently. To disentangle
TABLE A1. Fitting results for our model and the IFN response
model of Baccam et al.
Pony no.
Our model Baccam et al. model
SSE No. ofparameters
No. of
data SSE
No. of
parameters
No. of
dataa
1 0.23 6 16 0.14 7 15
2 0.16 6 16 0.21 7 15
3 0.46 6 16 0.17 7 15
4 0.17 6 16 0.15 7 15
5 0.20 6 16 0.22 7 15
6 0.16 6 16 0.19 7 15
Cumulative 1.38b 36 96 1.08c 42 90
a The estimated total proportion of cell death was not used for model fitting,
as total cell depletion results from this model.
b AIC cumulative, 290.1.
c AIC cumulative, 237.2.
FIG. A1. Interdependence between virus-related estimates. (a) Contour plot of SSE as a function of  (virus transmission) and p (virus
production per cell). The point (pmin, min) gives the minimum SSE (red circle). The hyperbolic curve is defined as follows:   p  constant 
min  pmin (red curve). (b to d) The contour plots for virus shedding (b) (in log scale), IFN production (c), and the abundance of refractory cells
(d) are drawn as functions of p and time (days postinfection).  is defined as min  pmin/p [i.e., pairs (p, ) from the red curve in panel a]. The
time scale (x axis) in panel d was cut short to 2.5 days, as the abundance of refractory cells was nearly constant beyond that point.
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these parameters, we would need detailed data on the proportions or
numbers of infected cells.
There is similar ambiguity with the immune parameters q and , as
the overall immune response depends on both the amount of IFN
available and its effect. These two parameters represent the rate of
production of IFN, which scales the absolute quantity, and how effec-
tive IFN is per unit. Again, there is an inverse relationship between
these two parameters: the product of the two determines the dynamics.
Sensitivity of parameter values. We investigated the effect on the
dynamics of the model when the parameter values were varied. The
virus peak, the time when the peak occurred, the IFN peak, and
the percentage of cell death were recorded as each of the parameter
values in the model was varied (Fig. A2 and A3). The “average”
estimates for the parameters in Table 2 were used as baseline values.
For the rest of the parameters, the values reported in Table 1 were
used as baseline values. The values for the estimated parameters (Ta-
ble 2) were varied from a factor of 1/10 to 10 times their estimated
values (Fig. A2). On the other hand, the values for the preset param-
eters (Table 1) were varied from 50% to 150% of their baseline values
(Fig. A3). The uncertainty expected in the estimates in Table 2 was the
main reason for having different factors for the parameters in Fig. A2
and A3. Both the transmission parameter, , and the virus production,
p, have a strong effect on all the dynamics of the model, increasing cell
death and virus and IFN peaks and decreasing the time for the virus
peak (Fig. A2). A similar effect was observed when the parameter m
was varied (Fig. A3). The IFN efficiency, , and IFN production, q,
have an effect on only the IFN peak and the percentage of cell death
(Fig. A2). The initial virus shedding, V0, seems to have any effect on
only the time when the virus peak occurs (Fig. A2). The eclipse phase
period, 1/k1, determines when the virus peak occurs, while the infec-
tious period, 1/, has an effect on the value of the peak (Fig. A3).
Similarly, the virus clearance rate, c, has a strong effect on the virus
peak, but it also affects the IFN peak and the percentage of cell death
(Fig. A3). The duration of the prerefractory state, 1/a, has a negative
effect on all the dynamics of the model (Fig. A3). The IFN clearance
rate, d, has a strong effect on the IFN peak and a mild effect on the
percentage of cell death (Fig. A2). The IFN-reduced production, n,
seems to affect only the amount of IFN at its peak (Fig. A3).
The value of the total number of epithelial cells, T0, scales the rates
of virus and IFN production per cell, p and q, respectively. To show
this, following a method described previously (45), let (T, E1, W, E2, R,
I, V, F) be the solution for system 1 with initial condition (T0, 0, 0, 0, 0, 0,
V0, 0). Then, it can be easily determined that (T˜, E˜1,W˜, E˜2, R˜, I˜,V˜, F˜) 
(T, E1, W, E2, R, I, V, F) is the solution of system 1 with the
new parameters p˜  (1/)p and q˜  (1/)q and for the initial condition
(T0, 0, 0, 0, 0, 0, V0, 0).
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